|
|
| A 443654 / AbbVie (0 Trials) |
|
| A 60 / MabVax (0 Trials) |
|
| A 866111 / AbbVie (0 Trials) |
|
| A 947864 / AbbVie (0 Trials) |
|
| A(H5N1) sa-mRNA influenza vaccine / CSL Behring (0 Trials) |
|
| A-1331852 / AbbVie (0 Trials) |
|
| A-1592668 / AbbVie (0 Trials) |
|
| A-319 / ITabMed (0 Trials) |
|
| A-329 / ITabMed (0 Trials) |
|
| A-337 / ITabMed (0 Trials) |
|
| A-620223 / AbbVie (0 Trials) |
|
| A-705253 / AbbVie (0 Trials) |
|
| A-967079 / AbbVie (1 Trials) |
|
| A000830 / Arcus Biosci (0 Trials) |
|
| A001421 / Arcus Biosci (0 Trials) |
|
| A006 / MeiraGTx (0 Trials) |
|
| A168 (ramucirumab biosimilar) / Sichuan Kelun Pharma (0 Trials) |
|
| A186 / Sichuan Kelun Pharma (0 Trials) |
|
| A204 / Sichuan Kelun Pharma (0 Trials) |
|
| A223 / Sichuan Kelun Pharma (0 Trials) |
|
| A244/B.63521 with ALFQ adjuvant / U.S. Army Medical Research and Development Command (0 Trials) |
|
| A277 / Sichuan Kelun Pharma (0 Trials) |
|
| A289 / Sichuan Kelun Pharma (0 Trials) |
|
| A295 / Sichuan Kelun Pharma (0 Trials) |
|
| A296 / Sichuan Kelun Pharma (0 Trials) |
|
| A2A-04 / A2A Pharma, OncoCube Therap (0 Trials) |
|
| A2A_C01 / A2A Pharma, Daewoong Pharma (0 Trials) |
|
| A2AR inhibitor / General Intermediates Canada (0 Trials) |
|
| A2B530 / A2 Biotherap (0 Trials) |
|
| A2B694 / A2 Biotherap (0 Trials) |
|
| A2BR inhibitor / Portage (0 Trials) |
|
| A337 / Sichuan Kelun Pharma (0 Trials) |
|
| A378 / Sichuan Kelun Pharma, Harbour BioMed (0 Trials) |
|
| A380 / Sichuan Kelun Pharma (0 Trials) |
|
| A3914 / Ipsen (0 Trials) |
|
| A416 / Sichuan Kelun Pharma (0 Trials) |
|
| A435 / Sichuan Kelun Pharma (0 Trials) |
|
| A4368 / Autophagy Sciences (0 Trials) |
|
| A5425 / Ipsen (0 Trials) |
|
| A6 / Angstrom (0 Trials) |
|
| A66 / The University of Auckland, Inje University College of Medicine (0 Trials) |
|
| A717 / Glycadia (0 Trials) |
|
| A947 / Arvinas, Roche (0 Trials) |
|
| AA 10090 / Arachnova (0 Trials) |
|
| AA 10091 / Arachnova (0 Trials) |
|
| AA-A225 / Actinium (0 Trials) |
|
| AAA603 / Novartis (0 Trials) |
|
| AAA614 / 3B Pharma, Novartis (0 Trials) |
|
| AAA817 / Novartis (0 Trials) |
|
| AAB-002 / J&J, Pfizer (0 Trials) |
|
| AADvac1 / Axon Neurosci (0 Trials) |
|
| AADvac2 / Axon Neurosci (0 Trials) |
|
| Aafact (monoclonal purified factor VIII) / Sanquin (2 Trials) |
|
| AAGP (PKX-001) / ProtoKinetix (1 Trials) |
|
| AAHI-SC2 Vaccine / ImmunityBio (0 Trials) |
|
| AAHI-SC3 Vaccine / ImmunityBio (0 Trials) |
|
| AAT-008 / AskAt, Ikena Oncology (0 Trials) |
|
| AAT-009 / AskAt (0 Trials) |
|
| AAV based GBM therapy / Lacerta Therap (0 Trials) |
|
| AAV based Rett syndrome therapy / Sarepta Therap, University of Massachusetts Boston (0 Trials) |
|
| AAV gene therapy / Capsida Biotherap, Eli Lilly (0 Trials) |
|
| AAV hmAb / Neurimmune, REGENXBIO (0 Trials) |
|
| AAV-based gene therapeutic / Fortress (0 Trials) |
|
| AAV-based gene therapeutic / Rocket Pharma (0 Trials) |
|
| AAV-CNGA3 / J&J, MeiraGTx (0 Trials) |
|
| AAV-GAD gene therapy / MeiraGTx (1 Trials) |
|
| AAV-Gcase D15 / Lysogene (0 Trials) |
|
| AAV-hTERT / Libella Gene Therap (0 Trials) |
|
| AAV-human bocavirus hybrid vector-based gene therapeutic / Pfizer (0 Trials) |
|
| AAV-KCC2 therapy / Axonis (0 Trials) |
|
| AAV-mediated gene therapy / DegenRx (0 Trials) |
|
| AAV-miR-ATXN2 / AviadoBio (0 Trials) |
|
| AAV-VLDLR / Armata (0 Trials) |
|
| AAV-ZFP-VEGF / Sangamo Therap (0 Trials) |
|
| AAV1-Follistatin / Milo Biotechnology (0 Trials) |
|
| AAV1-gSG / Genethon (0 Trials) |
|
| AAV2-neurturin / Biogen (0 Trials) |
|
| AAV2hAQP1 / MeiraGTx (0 Trials) |
|
| AAV8-VRC07 / National Institute of Allergy and Infectious Diseases, National Institutes of Health (0 Trials) |
|
| AAV9 viral vector containing HEXA and HEXB genes (TSHA-101) / Taysha Gene Therapies (0 Trials) |
|
| AAV:LF2 / Denali Therap (0 Trials) |
|
| AAVCOVID / Novartis, Massachusetts Eye and Ear, Massachusetts General Hospital (0 Trials) |
|
| AAVHSC 17 / Homology Medicines (0 Trials) |
|
| AAVLP-Aβ / 2A Pharma (0 Trials) |
|
| AAVLP-HIV / A2A Pharma (0 Trials) |
|
| AAVrh.10cuARSA / European Leukodystrophy Association, REGENXBIO, Public Assistance - Paris Hospitals (1 Trials) |
|
| AAVrh.10CUCLN2 / REGENXBIO (0 Trials) |
|
| AAVrh.10CUhCLN2 / Cornell University, National Institutes of Health (0 Trials) |
|
| AB 434 / Daiichi Sankyo (0 Trials) |
|
| AB-03 / Grifols (0 Trials) |
|
| AB-1002 / Bayer (0 Trials) |
|
| AB-1005 / Bayer (3 Trials) |
|
| AB-101 / Arbutus (0 Trials) |
|
| AB-1015 / ArsenalBio (0 Trials) |
|
| AB-101b / Alphyn Biologics (0 Trials) |
|
| AB-110 / Angiocrine (0 Trials) |
|
| AB-161 / Arbutus (0 Trials) |
|
| AB-2004 / Axial Biotherap (0 Trials) |
|
| AB-205 / Angiocrine (0 Trials) |
|
| AB-255 / Angiocrine (0 Trials) |
|
| AB-310 / Angiocrine (0 Trials) |
|
| AB-329 / Nuvation Bio (0 Trials) |
|
| AB-4000 series / ArsenalBio, BMS (0 Trials) |
|
| AB-4166 / Axial Biotherap (0 Trials) |
|
| AB-423 / Arbutus (0 Trials) |
|
| AB-452 / Arbutus (0 Trials) |
|
| AB-506 / Arbutus (0 Trials) |
|
| AB-510 / Angiocrine (0 Trials) |
|
| AB-836 / Arbutus (1 Trials) |
|
| AB-M101 / Assembly Biosci (0 Trials) |
|
| AB-M102 / Assembly Biosci (0 Trials) |
|
| AB-M103 / Assembly Biosci (0 Trials) |
|
| AB001 / Agastiya Biotech (0 Trials) |
|
| AB001 / AKSO Biopharma (0 Trials) |
|
| AB001 / ARTBIO (0 Trials) |
|
| AB002 / AKSO Biopharma (0 Trials) |
|
| AB003 / AKSO Biopharma (0 Trials) |
|
| AB011 / CARsgen (0 Trials) |
|
| AB012 / Aronora (0 Trials) |
|
| AB022 / Bayer, Aronora (0 Trials) |
|
| AB052 / Aronora (0 Trials) |
|
| AB1000 / Alveolus Bio (0 Trials) |
|
| Ab19 / Takeda (0 Trials) |
|
| Ab20004 / IASO BIO (0 Trials) |
|
| AB201 / ARCA Biopharma (0 Trials) |
|
| AB248 / Asher Biotherap (0 Trials) |
|
| AB421 / Arcus Biosci (0 Trials) |
|
| AB474 / Arcus Biosci (0 Trials) |
|
| AB598 / Arcus Biosci (0 Trials) |
|
| AB610 / Arcus Biosci (0 Trials) |
|
| AB79 / Takeda (0 Trials) |
|
| AB801 / Arcus Biosci (0 Trials) |
|
| AB821 / Asher Biotherap (0 Trials) |
|
| AB8779 / AB Science (0 Trials) |
|
| AB8939 / AB Science (0 Trials) |
|
| ABA-101 / Abata Therap (0 Trials) |
|
| abacavir / Generic mfg. (10 Trials) |
|
| abacavir/lamivudine / Generic mfg. (14 Trials) |
|
| abacavir/lamivudine/lopinavir/ritonavir (ABC/3TC/LPV/r) / Cipla, DNDi (0 Trials) |
|
| abacavir/lamivudine/zidovudine / Generic mfg. (5 Trials) |
|
| abagovomab (ACA 125) / Menarini (0 Trials) |
|
| abaloparatide transdermal patch (BA-058-TD) / Radius (0 Trials) |
|
| abaperidone (FI 8602) / Ferrer International (0 Trials) |
|
| abatacept biosimilar / Innovent Biologics (0 Trials) |
|
| abatacept biosimilar / BioXpress Therap (0 Trials) |
|
| ABBV-011 / AbbVie (0 Trials) |
|
| ABBV-022 / AbbVie (0 Trials) |
|
| ABBV-084 / AbbVie (0 Trials) |
|
| ABBV-1088 / AbbVie (0 Trials) |
|
| ABBV-119 / AbbVie (0 Trials) |
|
| ABBV-154 / AbbVie (0 Trials) |
|
| ABBV-167 / AbbVie (0 Trials) |
|
| ABBV-184 / AbbVie (0 Trials) |
|
| ABBV-1882 / AbbVie (0 Trials) |
|
| ABBV-191 / AbbVie (0 Trials) |
|
| ABBV-2B04 / AbbVie (0 Trials) |
|
| ABBV-303 / AbbVie (0 Trials) |
|
| ABBV-319 / AbbVie (0 Trials) |
|
| ABBV-3373 / AbbVie (0 Trials) |
|
| ABBV-382 / AbbVie (0 Trials) |
|
| ABBV-383 IV / AbbVie (0 Trials) |
|
| ABBV-428 / AbbVie (1 Trials) |
|
| ABBV-453 / AbbVie (0 Trials) |
|
| ABBV-467 / AbbVie (0 Trials) |
|
| ABBV-514 / AbbVie (0 Trials) |
|
| ABBV-525 / AbbVie (0 Trials) |
|
| ABBV-552 / AbbVie (0 Trials) |
|
| ABBV-623 / AbbVie (0 Trials) |
|
| ABBV-637 / AbbVie (0 Trials) |
|
| ABBV-668 IR / AbbVie (0 Trials) |
|
| ABBV-672 / AbbVie (0 Trials) |
|
| ABBV-706 / AbbVie (0 Trials) |
|
| ABBV-712 / AbbVie (0 Trials) |
|
| ABBV-744 / AbbVie (0 Trials) |
|
| ABBV-8736 / AbbVie (0 Trials) |
|
| ABBV-916 / AbbVie (0 Trials) |
|
| ABBV-990 / AbbVie (0 Trials) |
|
| ABBV-992 / AbbVie (0 Trials) |
|
| ABBV-CLS-579 / AbbVie, Calico Life Sciences (0 Trials) |
|
| ABBV-RGX-314 / REGENXBIO, AbbVie (6 Trials) |
|
| ABC008 / Abcuro (0 Trials) |
|
| ABC131 / Apogee Biotech (0 Trials) |
|
| Abcertin (imiglucerase) / ISU Abxis (0 Trials) |
|
| Abdala (CIGB-66) / Center for Genetic Engineering and Biotechnology (0 Trials) |
|
| Abecma (idecabtagene vicleucel) / BMS, 2seventy bio (8 Trials) |
|
| abediterol (AZD-0548) / AstraZeneca (1 Trials) |
|
| Abegrin (etaracizumab) / AstraZeneca (0 Trials) |
|
| abelacimab (MAA868) / Anthos Therap (0 Trials) |
|
| Abelcet (amphotericin B) / Bioprofarma, Leadiant Biosci (0 Trials) |
|
| abequolixron (RGX-104) / Inspirna (1 Trials) |
|
| abexinostat (CG-781) / Xynomic (11 Trials) |
|
| AbGn-107 / AltruBio (0 Trials) |
|
| AbGn-207 / AltruBio (0 Trials) |
|
| AbGn-7 / AltruBio (0 Trials) |
|
| ABI-1968 topical cream / Antiva Biosci (0 Trials) |
|
| ABI-2280 / Antiva Biosci (0 Trials) |
|
| ABI-231 intratumoral / (0 Trials) |
|
| ABI-4334 / Assembly Biosci (0 Trials) |
|
| ABI-H2158 / Assembly Biosci (1 Trials) |
|
| ABI-H3733 / Assembly Biosci, BeiGene (0 Trials) |
|
|